Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> FOOD AND DRUG ADMINISTRATION Latest News

JUL 18, 2013 - Yahoo! News

A Must Read - Share

Celgene to stop blood cancer trial due to high death rates

(Reuters) - Celgene Corp said it will stop a late-stage trial of its blood cancer drug Revlimid after it observed a higher number of deaths in patients taking the drug compared to those on another treatment. Revlimid is Celgene's flagship blood cancer drug and is already approved for use in various types of blood cancer, including multiple myeloma and mantle cell lymphoma. Celgene shares were down 2 percent to $134 in premarket trading. The trial was placed on a clinical hold by the U.S. Food and Drug Administration on July 12, Celgene said. ...

Tags: Celgene to stop blood cancer trial due to high death rates,  Food And Drug Administration Latest News